Status:
RECRUITING
IMMunological ResPonse Assessment AfteR Acute ISchemic Stroke Treated with Endovascular Therapy (IMPRESS)
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Ischemic Stroke
Thrombectomy
Eligibility:
All Genders
18+ years
Brief Summary
IMPRESS study aims to describe the immuno-inflammatory and thrombo-inflammatory profiles during the first 24/36 hours of treatment of patients suffering from AIC treated with TM, and to study the poss...
Detailed Description
Stroke is the second leading cause of death worldwide, the leading cause of acquired disability and the second leading cause of dementia. Ischaemic strokes account for 80% of strokes, 40% of which are...
Eligibility Criteria
Inclusion
- Patient with an acute ischemic stroke for which treatment with mechanical thrombectomy is indicated, whether or not thrombectomy is performed,
- Having received informed information about the study and having signed a consent to participate in the study (if this is not possible: information and consent of the trusted support person or family member if present; emergency inclusion if absent);
- Affiliated or beneficiary of a social security scheme or equivalent.
- Non inclusion Criteria:
- Pregnant or breast-feeding women
- Patient benefiting from a legal protection measure
Exclusion
- None.
Key Trial Info
Start Date :
February 23 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 23 2028
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04663399
Start Date
February 23 2023
End Date
May 23 2028
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Fondation Adolphe de Rothschild
Paris, Paris, France, 75019